Sensato Investors’s Dr. Reddy's Laboratories RDY Stock Holding History

Sensato Investors’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-62,405	Closed	-$468K	–	74
2019 Q2	$468K	Sell	62,405 -50,280	-45%	-$395K	0.14%	64
2019 Q1	$913K	Sell	112,685 -11,720	-9%	-$89K	0.26%	51
2018 Q4	$938K	Buy	124,405 +77,755	+167%	+$547K	0.25%	65
2018 Q3	$323K	Buy	+46,650	New	+$312K	0.06%	81
2016 Q1	–	Sell	-121,410	Closed	-$1.12M	–	96
2015 Q4	$1.12M	Sell	121,410 -813,615	-87%	-$8.91M	0.21%	56
2015 Q3	$12M	Buy	935,025 +716,750	+328%	+$8.9M	2.24%	14
2015 Q2	$2.42M	Buy	+218,275	New	+$2.41M	0.51%	41

Other funds holding RDY

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Sensato Investors's RDY Position: Q3 2019 in Review

Sensato Investors sold out of Dr. Reddy's Laboratories (RDY) in Q3 2019, closing a stake of 62,405 shares — an estimated $468K sold.

Sensato Investors first reported a position in RDY in Q2 2015 and held it in 7 quarters. The position peaked at $12M in Q3 2015. 152 funds tracked by Wall St. Rank hold RDY as of Q3 2019.

Sensato Investors reported no remaining Dr. Reddy's Laboratories position as of Q3 2019 after selling out during the quarter.
Sensato Investors sold 62,405 Dr. Reddy's Laboratories shares in Q3 2019, an estimated $468K.
Sensato Investors first reported a position in Dr. Reddy's Laboratories in Q2 2015 and held it in 7 quarters.
Sensato Investors's Dr. Reddy's Laboratories position peaked at $12M in Q3 2015.
152 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2019.

Based on Sensato Investors's 13F filing for Q3 2019, filed 14 Nov 2019.